[Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects; D014594:Uterine Neoplasms / Q000188:drug therapy*
D004273:DNA, Neoplasm; D008525:Medroxyprogesterone
Effetti della terapia con medrossiprogesterone (MAP) sul contenuto in DNA dell'adenocarcinoma dell'endometrio umano.